bt_bb_section_bottom_section_coverage_image

DogsPMC: Clinical Response of Metastatic Breast Cancer…

April 30, 2021by Nate0
https://buddycustard.com/wp-content/uploads/2021/04/IMAGEN-14-1280x800-1.jpg

Abstract

The present article describes the ongoing (partial) remission of a female patient (41 years old) from estrogen receptor (ER)-positive/progesterone receptor (PR)-negative metastatic breast cancer in response to a combination treatment directed towards the revitalization of the mitochondrial respiratory chain (oxidative phosphorylation), the suppression of NF-kappaB as a factor triggering the inflammatory response, and chemotherapy with capecitabine. The reduction of tumor mass was evidenced by a continuing decline of CA15-3 and CEA tumor marker serum levels and 18FDG-PET-CT plus magnetic resonance (MR) imaging. It is concluded that such combination treatment might be a useful option for treating already formed metastases and for providing protection against the formation of metastases in ER positive breast cancer. The findings need to be corroborated by clinical trials. Whether similar results can be expected for other malignant tumor phenotypes relying on glycolysis as the main energy source remains to be elucidated.

Keywords: breast cancer, chemotherapy, respiratory chain, Warburg effect, inflammatory chain, partial remission

Read more about this study: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756422/

 

Leave a Reply

Your email address will not be published. Required fields are marked *

https://buddycustard.com/wp-content/uploads/2021/04/Capture.png
About
1451 W. Cypress Creek Rd. Suite 300 Ft. Lauderdale, FL 33309
+888 286 2925
info@buddycustard.com
Newsletter